MEILIN LIANG: Open Payments
NPI 1760092126 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 2 payments from 2 companies in 2025. Trend: 2023 $21 · 2024 $80 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: DEXCOM G7 GSS (161), VONVENDI.
Industry payments across CA — which companies pay providers there.
